Search Results - "Kaneuchi, M"

Refine Results
  1. 1

    Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis by Dong, P, Karaayvaz, M, Jia, N, Kaneuchi, M, Hamada, J, Watari, H, Sudo, S, Ju, J, Sakuragi, N

    Published in Oncogene (04-07-2013)
    “…The tumor suppressor gene p53 has been implicated in the regulation of epithelial–mesenchymal transition (EMT) and tumor metastasis by regulating microRNA…”
    Get full text
    Journal Article
  2. 2

    Clinical applications of analysis of plasma circulating complete hydatidiform mole pregnancy-associated miRNAs in gestational trophoblastic neoplasia: A preliminary investigation by Miura, K, Hasegawa, Y, Abe, S, Higashijima, A, Miura, S, Mishima, H, Kinoshita, A, Kaneuchi, M, Yoshiura, K, Masuzaki, H

    Published in Placenta (Eastbourne) (01-09-2014)
    “…Abstract The aim of this study was to investigate the clinical application of plasma complete hydatidiform mole pregnancy-associated microRNAs (CHM-miRNAs:…”
    Get full text
    Journal Article
  3. 3

    Study of edema reduction patterns during the treatment phase of complex decongestive physiotherapy for extremity lymphedema by Yamamoto, T, Todo, Y, Kaneuchi, M, Handa, Y, Watanabe, K, Yamamoto, R

    Published in Lymphology (01-06-2008)
    “…Shortening the treatment phase of complex decongestive physiotherapy (CDP) is extremely important both for individual patients and medical economics. In 83…”
    Get full text
    Journal Article
  4. 4

    High-grade broad ligament cancer of müllerian origin: immunohistochemical analysis of a case and review of the literature by Handa, Y, Kato, H, Kaneuchi, M, Saitoh, Y, Yamashita, K

    “…Malignant neoplasms arising in the broad ligament are quite unusual. Although tens of broad ligament cancers of low potential malignancy have been documented,…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity by Kawamura, M, Yamashita, T, Segawa, K, Kaneuchi, M, Shindoh, M, Fujinaga, K

    Published in Oncogene (06-06-1996)
    “…Cancer-related mutations of the p53 tumor suppressor gene are clustered in the four so-called 'hot spots', codons 175, 248, 273 and 281/282. By using…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Sonodynamically induced cell damage with 4'-O-tetrahydropyranyladriamycin, THP by Yumita, N, Kaneuchi, M, Okano, Y, Nishigaki, R, Umemura, K, Umemura, S

    Published in Anticancer research (01-01-1999)
    “…4'-O-tetrahydropyranyladriamycin (THP) is a novel anthracycline derivative with cardiotoxicity significantly lower than ADM. In this study, the ultrasonically…”
    Get more information
    Journal Article
  10. 10

    CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor α and estrogen receptor β expressions by SASAKI, Masahiro, TANAKA, Yuichiro, KANEUCHI, Masanori, SAKURAGI, Noriaki, DAHIYA, Rajvir

    Published in Cancer research (Chicago, Ill.) (15-07-2003)
    “…The estradiol metabolites by CYP1B1 received particular attention because of their causative role in malignant transformation of endometrium. We hypothesize…”
    Get full text
    Journal Article
  11. 11

    Multiple promoters of Catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer by SASAKI, Masahiro, KANEUCHI, Masanori, SAKURAGI, Noriaki, DAHIYA, Rajvir

    Published in Cancer research (Chicago, Ill.) (15-06-2003)
    “…Catechol-O-methyltransferase (COMT) plays an important role in estrogen-induced cancers because COMT inactivates catechol estrogens that have cancer-promoting…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer by Tanaka, Yuichiro, Sasaki, Masahiro, Kaneuchi, Masanori, Shiina, Hiroaki, Igawa, Mikio, Dahiya, Rajvir

    “…Various carcinogenic factors including estrogen metabolites play a role in malignant transformation. These metabolites are formed in part, as a result of the…”
    Get full text
    Journal Article
  16. 16

    WT1 and WT1‐AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma by Kaneuchi, Masanori, Sasaki, Masahiro, Tanaka, Yuichiro, Shiina, Hiroaki, Yamada, Hideto, Yamamoto, Ritsu, Sakuragi, Noriaki, Enokida, Hideki, Verma, Mukesh, Dahiya, Rajvir

    Published in Cancer (01-11-2005)
    “…BACKGROUND Ovarian clear cell adenocarcinoma is associated with one of the poorest prognoses among human epithelial ovarian cancers. The authors hypothesized…”
    Get full text
    Journal Article
  17. 17

    Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers by Sasaki, Masahiro, Kaneuchi, Masanori, Fujimoto, Seiichiro, Tanaka, Yuichiro, Dahiya, Rajvir

    Published in Molecular and cellular endocrinology (28-04-2003)
    “…Multiple promoters and differential splicing of 5′ upstream exons are often found in various nuclear receptor genes including steroid receptors. Three…”
    Get full text
    Journal Article
  18. 18

    Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF by Kaneuchi, Masanori, Sasaki, Masahiro, Tanaka, Yuichiro, Yamamoto, Ritsu, Sakuragi, Noriaki, Dahiya, Rajvir

    Published in International journal of oncology (01-10-2003)
    “…Resveratrol and other polyphenols have anti-carcinogenic and anti-tumorigenic activities in various carcinomas. However, such studies are limited in…”
    Get more information
    Journal Article
  19. 19

    Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1 by Kaneuchi, Masanori, Sasaki, Masahiro, Tanaka, Yuichiro, Sakuragi, Noriaki, Fujimoto, Seiichiro, Dahiya, Rajvir

    Published in International journal of oncology (01-01-2003)
    “…Quercetin and other polyphenols have anti-carcinogenic and anti-tumorigenic activity in various organs, however, studies of this activity are lacking in…”
    Get more information
    Journal Article
  20. 20

    Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer by Kaneuchi, Masanori, Sasaki, Masahiro, Tanaka, Yuichiro, Shiina, Hiroaki, Verma, Mukesh, Ebina, Yasuhiko, Nomura, Eiji, Yamamoto, Ritsu, Sakuragi, Noriaki, Dahiya, Rajvir

    “…We hypothesize that 14-3-3 sigma gene expression and its regulation by methylation can characterize histological types of primary human epithelial ovarian…”
    Get full text
    Journal Article